Insider Trading February 2, 2026

Palomar CEO Mac Armstrong Sells $927K in Stock, Exercises RSUs as Company Reports Strong Q3 2025

Armstrong reduced a portion of his holdings in late January while also receiving vested shares; Palomar posts revenue and earnings beats and closes Gray Surety acquisition with new financing

By Jordan Park PLMR
Palomar CEO Mac Armstrong Sells $927K in Stock, Exercises RSUs as Company Reports Strong Q3 2025
PLMR

Palomar Holdings' CEO and chairman Mac Armstrong sold 7,604 shares across January 29 and 31, 2026, for about $927,354 at a weighted average price between $121.7437 and $122.0432. Simultaneously, Armstrong received 14,771 restricted stock units through option exercises at no cost. The insurer reported a strong third quarter for 2025, beating EPS and revenue estimates, and completed the acquisition of The Gray Casualty & Surety Company backed by $450 million in financing. Equity research firm Keefe, Bruyette & Woods raised its price target to $170 and retained an Outperform rating.

Key Points

  • CEO Mac Armstrong sold 7,604 shares on January 29 and 31, 2026, for about $927,354 at weighted prices between $121.7437 and $122.0432.
  • Armstrong also acquired 14,771 RSU shares through option exercises at $0.00 and now directly owns 98,904 shares, with an additional 348,388 held indirectly via family trust.
  • Palomar beat Q3 2025 EPS and revenue estimates, completed the Gray Surety acquisition, raised $450 million in financing, and received an increased price target from Keefe, Bruyette & Woods.

Mac Armstrong, the chief executive officer and chairman of Palomar Holdings, Inc. (NASDAQ:PLMR), completed a set of insider transactions at the end of January 2026 that included both sales and stock unit vesting. On January 29 and 31, 2026, Armstrong sold a total of 7,604 shares of Palomar common stock for roughly $927,354, with the trades executed at a weighted average price ranging from $121.7437 to $122.0432.

At the same time as those dispositions, Armstrong also acquired a total of 14,771 shares via restricted stock unit (RSU) exercises tied to company options; those shares were recorded at an exercise price of $0.00. Following these moves, Armstrong's direct ownership of Palomar stock stands at 98,904 shares, and he holds an additional 348,388 shares indirectly through the Armstrong Family Trust.

Palomar, a specialty insurer with a market capitalization reported at $3.29 billion, was trading at $124.22 per share and carried a price-to-earnings ratio of 19.36 at the time of the transactions. External analysis noted in company materials characterized Palomar as appearing undervalued relative to its growth prospects, citing a price/earnings-to-growth (PEG) ratio of 0.36.

The insider activity coincides with a quarterly performance update that showed notable upside. For the third quarter of 2025, Palomar reported earnings per share of $2.01, ahead of an expected $1.57 consensus and representing a 28.03% positive surprise. Revenue for the period came in at $597.2 million versus projected revenues of $540.07 million.

Corporate activity during the quarter included Palomar's completion of its acquisition of The Gray Casualty & Surety Company. To finance the transaction and related needs, Palomar secured $450 million in financing composed of a $150 million revolving facility and a $300 million term loan. Separately, BCP finalized the sale of Gray Surety to Palomar, completing that element of the deal pipeline.

On the research front, Keefe, Bruyette & Woods updated its view of the company by raising its price target to $170 from $164 while maintaining an Outperform rating. The revised target was described as reflecting 19.3 times the firm's updated 2026 earnings per share estimate.


Key facts

  • Armstrong sold 7,604 shares on Jan. 29 and 31, 2026, for approximately $927,354 at weighted prices of $121.7437 to $122.0432.
  • Armstrong received 14,771 RSU shares through option exercises at an exercise price of $0.00 and now directly owns 98,904 shares with 348,388 held indirectly.
  • Palomar reported Q3 2025 EPS of $2.01 and revenue of $597.2 million, both above consensus estimates, and closed the Gray Surety acquisition backed by $450 million of financing.

Takeaway

The transactions show concurrent insider selling and vesting activity against a backdrop of stronger-than-expected quarterly results and a strategic acquisition supported by fresh financing. Public valuations and third-party research updates reflect investor and analyst reassessment of Palomar's outlook.

Risks

  • Insider sales may be interpreted variably by market participants, which could affect investor sentiment in the insurance and financial sectors.
  • The completed acquisition and the $450 million financing package introduce integration and leverage considerations that affect Palomar's capital structure and risk profile in the specialty insurance sector.
  • Analyst valuations and price targets are tied to forward earnings estimates; changes to those estimates or execution on growth assumptions could alter investor expectations in the financial markets.

More from Insider Trading

Spyre Therapeutics CFO Disposes $370K in Stock, Exercises Options Same Day as Trial Timelines Accelerate Apr 3, 2026 Fold Holdings CEO completes modest stock sale to cover RSU tax obligations Apr 3, 2026 Spyre Therapeutics CEO Executes $739,912 Stock Sale as Trials Accelerate Apr 3, 2026 Spyre Therapeutics CMO Sells Shares, Exercises Options as Trials Accelerate Apr 3, 2026 Fold CFO Sells Small Stake to Meet Tax Withholding as Company Faces Revenue Shortfall Apr 3, 2026